Latest

What MS research is missing about menopause

New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.

What’s new and what’s next

A look at what we're building for 2026.

Long-term study reinforces safety of COVID-19 vaccines in MS

New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.

July 2024 Newsletter

We know how important research is to you, so this month we’re diving into evidence supporting staying active with MS. Plus, celebrate the visionaries behind iConquerMS!

July 2024 iConquerMS Spotlight

iConquerMS will launch the largest study ever on a new treatment for MS fatigue.

July 2024 Research Spotlight

Research studies include one for Kesimpta users, exploration into childhood experiences, and a study on exercise and wellness for wheelchair users.

July 2024 Donor’s Corner

Your donation to ACP enables iConquerMS to bring together all people affected by MS to understand the disease and search for solutions.

July Newsletter Snapshot

Not enough time to read an entire newsletter? Our July newsletter snapshot contains the highlights in a quick, easy to read format.

Heat Hits Hard

Heat intolerance is a common, debilitating MS symptom. Discover ways to stay cool and find relief!